Supplement Manufacturers Must Be at the Codex Table

Of late, there has been a noticeable uptick in international regulatory activity. Monitoring and evaluating the impacts of this activity hijacks much of my daily workload. During the past several months, I’ve watched countries’ regulatory actions increasingly focus on “doing their own thing,” which is a problem because it creates unnecessary and burdensome barriers to ...